IBDEI0XO ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16625,0)
 ;;=196.3^^92^940^99
 ;;^UTILITY(U,$J,358.3,16625,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16625,1,4,0)
 ;;=4^196.3
 ;;^UTILITY(U,$J,358.3,16625,1,5,0)
 ;;=5^Mets to Lymph Nodes,Axillary Or Brachial
 ;;^UTILITY(U,$J,358.3,16625,2)
 ;;=^267317
 ;;^UTILITY(U,$J,358.3,16626,0)
 ;;=196.0^^92^940^100
 ;;^UTILITY(U,$J,358.3,16626,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16626,1,4,0)
 ;;=4^196.0
 ;;^UTILITY(U,$J,358.3,16626,1,5,0)
 ;;=5^Mets to Lymph Nodes,Cervical
 ;;^UTILITY(U,$J,358.3,16626,2)
 ;;=Lymph Nodes^267314
 ;;^UTILITY(U,$J,358.3,16627,0)
 ;;=196.1^^92^940^101
 ;;^UTILITY(U,$J,358.3,16627,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16627,1,4,0)
 ;;=4^196.1
 ;;^UTILITY(U,$J,358.3,16627,1,5,0)
 ;;=5^Mets to Lymph Nodes,Mediastinal 
 ;;^UTILITY(U,$J,358.3,16627,2)
 ;;=Lymph Nodes^267315
 ;;^UTILITY(U,$J,358.3,16628,0)
 ;;=196.8^^92^940^102
 ;;^UTILITY(U,$J,358.3,16628,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16628,1,4,0)
 ;;=4^196.8
 ;;^UTILITY(U,$J,358.3,16628,1,5,0)
 ;;=5^Mets to Lymph Nodes,Multiple Sites
 ;;^UTILITY(U,$J,358.3,16628,2)
 ;;=^267320
 ;;^UTILITY(U,$J,358.3,16629,0)
 ;;=V10.51^^92^940^56
 ;;^UTILITY(U,$J,358.3,16629,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16629,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,16629,1,5,0)
 ;;=5^H/O Bladder Cancer
 ;;^UTILITY(U,$J,358.3,16629,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,16630,0)
 ;;=V10.3^^92^940^57
 ;;^UTILITY(U,$J,358.3,16630,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16630,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,16630,1,5,0)
 ;;=5^H/O Breast Cancer
 ;;^UTILITY(U,$J,358.3,16630,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,16631,0)
 ;;=V10.41^^92^940^58
 ;;^UTILITY(U,$J,358.3,16631,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16631,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,16631,1,5,0)
 ;;=5^H/O Cervical Cancer
 ;;^UTILITY(U,$J,358.3,16631,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,16632,0)
 ;;=V10.05^^92^940^59
 ;;^UTILITY(U,$J,358.3,16632,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16632,1,4,0)
 ;;=4^V10.05
 ;;^UTILITY(U,$J,358.3,16632,1,5,0)
 ;;=5^H/O Colon Cancer
 ;;^UTILITY(U,$J,358.3,16632,2)
 ;;=H/O Colon Cancer^295207
 ;;^UTILITY(U,$J,358.3,16633,0)
 ;;=V10.03^^92^940^60
 ;;^UTILITY(U,$J,358.3,16633,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16633,1,4,0)
 ;;=4^V10.03
 ;;^UTILITY(U,$J,358.3,16633,1,5,0)
 ;;=5^H/O Esophageal Cancer
 ;;^UTILITY(U,$J,358.3,16633,2)
 ;;=^295205
 ;;^UTILITY(U,$J,358.3,16634,0)
 ;;=V10.60^^92^940^62
 ;;^UTILITY(U,$J,358.3,16634,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16634,1,4,0)
 ;;=4^V10.60
 ;;^UTILITY(U,$J,358.3,16634,1,5,0)
 ;;=5^H/O Leukemia
 ;;^UTILITY(U,$J,358.3,16634,2)
 ;;=H/O Leukemia^295231
 ;;^UTILITY(U,$J,358.3,16635,0)
 ;;=V10.11^^92^940^63
 ;;^UTILITY(U,$J,358.3,16635,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16635,1,4,0)
 ;;=4^V10.11
 ;;^UTILITY(U,$J,358.3,16635,1,5,0)
 ;;=5^H/O Lung Cancer
 ;;^UTILITY(U,$J,358.3,16635,2)
 ;;=H/O Lung Cancer^295211
 ;;^UTILITY(U,$J,358.3,16636,0)
 ;;=V10.79^^92^940^64
 ;;^UTILITY(U,$J,358.3,16636,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16636,1,4,0)
 ;;=4^V10.79
 ;;^UTILITY(U,$J,358.3,16636,1,5,0)
 ;;=5^H/O Lymphoma
 ;;^UTILITY(U,$J,358.3,16636,2)
 ;;=H/O Lymphoma^295238
 ;;^UTILITY(U,$J,358.3,16637,0)
 ;;=V10.82^^92^940^65
 ;;^UTILITY(U,$J,358.3,16637,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16637,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,16637,1,5,0)
 ;;=5^H/O Malig Melanoma Of Skin
 ;;^UTILITY(U,$J,358.3,16637,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,16638,0)
 ;;=V10.02^^92^940^68
 ;;^UTILITY(U,$J,358.3,16638,1,0)
 ;;=^358.31IA^5^2
